Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025)
Vicarious Surgical (RBOT) reported Cash from Investing Activities of $9.7 million for Q3 2025, up 2069.92% year-over-year from $446652.7 in Q3 2024, and down 34.6% on a QoQ basis from $14.8 million in Q2 2025.
Vicarious Surgical (RBOT) has 6 years of Cash from Investing Activities data on file, last reported at $9.7 million in Q3 2025.
- Quarterly Cash from Investing Activities rose 2069.92% year-over-year to $9.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $43.6 million (up 1814.16% YoY) and the FY2024 annual result came in at $6.9 million, up 114.99% from the prior year.
- Cash from Investing Activities retreated to $9.7 million in Q3 2025 per RBOT's latest filing, from $14.8 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $14.8 million in Q2 2025 and bottomed at -$43.8 million in Q1 2023.
- The 5-year median for Cash from Investing Activities is -$492000.0 (2024), against an average of -$865105.3.
- The widest annual swing landed in 2023, when Cash from Investing Activities sank 2067.56%; it then jumped 3303.47% in 2025.
- Tracing RBOT's Cash from Investing Activities over 5 years: stood at -$867000.0 in 2021, then dropped by 14.42% to -$992000.0 in 2022, then soared by 608.57% to $5.0 million in 2023, then soared by 186.42% to $14.4 million in 2024, then sank by 32.93% to $9.7 million in 2025.
- Per Business Quant, the three latest RBOT Cash from Investing Activities figures stand at $9.7 million (Q3 2025), $14.8 million (Q2 2025), and $4.6 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.69 Mn |
| Sep 30, 2025 | 9.69 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Sep 30, 2024 | -492,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Jun 30, 2024 | -6.95 Mn |
| Jun 30, 2024 | -6.95 Mn |
| Mar 31, 2024 | -144,000.00 |
| Mar 31, 2024 | -144,000.00 |
| Dec 31, 2023 | 5.05 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | -644,000.00 |
| Sep 30, 2023 | -644,000.00 |
| Jun 30, 2023 | -6.36 Mn |
| Jun 30, 2023 | -6.36 Mn |
| Mar 31, 2023 | -43.83 Mn |
| Mar 31, 2023 | -43.83 Mn |
| Dec 31, 2022 | -992,000.00 |
| Dec 31, 2022 | -992,000.00 |
| Sep 30, 2022 | -782,000.00 |
| Sep 30, 2022 | -782,000.00 |
| Jun 30, 2022 | -1.56 Mn |
| Jun 30, 2022 | -1.56 Mn |
| Mar 31, 2022 | -2.02 Mn |
| Mar 31, 2022 | -2.02 Mn |
| Dec 31, 2021 | -867,000.00 |
| Dec 31, 2021 | -867,000.00 |
| Sep 30, 2021 | -82,000.00 |
| Sep 30, 2021 | -82,000.00 |
| Jun 30, 2021 | -212,000.00 |
| Jun 30, 2021 | -212,000.00 |
| Mar 31, 2021 | -128,000.00 |
| Mar 31, 2021 | -128,000.00 |
| Dec 31, 2020 | -345.00 Mn |
| Dec 31, 2020 | -345.00 Mn |
| Sep 30, 2020 | -345.00 Mn |
| Sep 30, 2020 | -345.00 Mn |